A large Scandinavian study reopens the debate on beta-blockers after myocardial infarction, revealing selective benefits.

Two NEJM trials report conflicting results on long-term beta-blockers after MI in patients with preserved ejection fraction, ...

Our findings in a large, population-based registry of over 20 000 patients with a recent hospitalization for documented HF suggest that prescription of a non-selective beta-blocker is associated with ...

Credit: Getty Images. A discussion of the use of beta-blocker therapy following AMI, with Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD. The role of beta-blockers after acute ...

In a recent meta-analysis which included individual-patient data from five randomized trials, beta-blocker therapy did not ...

Please provide your email address to receive an email when new articles are posted on . Optimal duration of beta-blockers after a heart attack remains unknown. The ABYSS trial provides new insights on ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Beta-blocker use did not reduce risk for death or new MI ...

CHICAGO -- Initiating low-dose beta-blockers prior to discharge in heart failure patients hospitalized for worsening symptoms significantly improves the use of a drug that has been shown in previous ...

Beta blockers—drugs commonly prescribed for a range of cardiac conditions, including heart attacks—provide no clinical benefit for patients who have had an uncomplicated myocardial infarction with ...

SAN DIEGO -- The beta-blocker bisoprolol did not improve exacerbations in chronic obstructive pulmonary disease (COPD) patients, a randomized clinical trial found. Exacerbations requiring antibiotics, ...